Chun‐Wei Hsu

发表

Hypoxic drive caused Type 3 neovascularization in a preclinical model of exudative age-related macular degeneration.

A. Bassuk, S. Tsang, V. Mahajan, 2019, Human molecular genetics.

Gene Therapy Restores Mfrp and Corrects Axial Eye Length

G. Velez, A. Bassuk, S. Tsang, 2017, Scientific Reports.

Reduced adiponectin:leptin ratio associated with inhalation exposure to vinyl chloride monomer.

Ching‐Chang Lee, Jung-Wei Chang, S. Uang, 2019, The Science of the total environment.

CAPN5 genetic inactivation phenotype supports therapeutic inhibition trials

Katherine J. Wert, G. Velez, A. Bassuk, 2019, Human mutation.

3 1 2 | L I E T a L . | M O L M E D 1 8 : 1 3 1 2 -1 3 1 9 , 2 0 1 2

S. Tsang, D. Egli, Wen-Hsuan Wu, 2022 .

Catenin delta-1 (CTNND1) phosphorylation controls the mesenchymal to epithelial transition in astrocytic tumors.

M. Howard, A. Bassuk, S. Tsang, 2016, Human molecular genetics.

Genetic Rescue Reverses Microglial Activation in Preclinical Models of Retinitis Pigmentosa.

S. Tsang, Chyuan-Sheng Lin, Wen-Hsuan Wu, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Effect of the ILE86TER mutation in the γ subunit of cGMP phosphodiesterase (PDE6) on rod photoreceptor signaling.

G. Fain, S. Tsang, M. Woodruff, 2012, Cellular signalling.

Halting progressive neurodegeneration in advanced retinitis pigmentosa.

S. Tsang, L. Bonet-Ponce, Chyuan-Sheng Lin, 2015, The Journal of clinical investigation.

Genetic rescue models refute nonautonomous rod cell death in retinitis pigmentosa

S. Tsang, C. Wahl-Schott, Chyuan-Sheng Lin, 2017, Proceedings of the National Academy of Sciences.

HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy

Katherine J. Wert, J. Sparrow, Nan-Kai Wang, 2023, EMBO molecular medicine.

Silencing of tuberin enhances photoreceptor survival and function in a preclinical model of retinitis pigmentosa (an american ophthalmological society thesis).

Katherine J. Wert, S. Tsang, V. Mahajan, 2014, Transactions of the American Ophthalmological Society.

Mechanisms of neurodegeneration in a preclinical autosomal dominant retinitis pigmentosa knock-in model with a RhoD190N mutation

G. Velez, A. Bassuk, V. Mahajan, 2019, Cellular and Molecular Life Sciences.

Mechanisms of neurodegeneration in a preclinical autosomal dominant retinitis pigmentosa knock-in model with a RhoD190N mutation

G. Velez, A. Bassuk, S. Tsang, 2019, Cellular and Molecular Life Sciences.

Mice with a D190N Mutation in the Gene Encoding Rhodopsin: A Model for Human Autosomal-Dominant Retinitis Pigmentosa

S. Tsang, Chyuan-Sheng Lin, J. P. Greenberg, 2012, Molecular medicine.

Mice with a D 190 N Mutation in the Gene Encoding Rhodopsin : A Model for Human Autosomal-Dominant Retinitis Pigmentosa

S. Tsang, Chyuan-Sheng Lin, J. P. Greenberg, 2012 .

HTRA1, an age‐related macular degeneration protease, processes extracellular matrix proteins EFEMP1 and TSP1

Jesse D. Sengillo, A. Bassuk, S. Tsang, 2018, Aging cell.

PKM2 ablation enhanced retinal function and survival in a preclinical model of retinitis pigmentosa

S. Tsang, Ethan Zhang, Tingting Yang, 2019, bioRxiv.

Reprogramming towards anabolism impedes degeneration in a preclinical model of retinitis pigmentosa.

A. Bassuk, S. Tsang, V. Mahajan, 2016, Human molecular genetics.

Gene therapy in patient-specific stem cell lines and a preclinical model of retinitis pigmentosa with membrane frizzled-related protein defects.

S. Tsang, L. Yannuzzi, D. Egli, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration.

S. Tsang, V. Mahajan, J. Hurley, 2016, The Journal of clinical investigation.

Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines.

S. Tsang, D. Egli, Wen-Hsuan Wu, 2014, Human molecular genetics.

CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa.

Wen-Hsuan Wu, Y. Tsai, Xuan Cui, 2022, Molecular Therapy.

Gene therapy in patient-specific stem cell lines and mice with membrane frizzled-related protein (MFRP) defects

S. Tsang, L. Yannuzzi, D. Egli, 2014 .

Therapeutic Margins in a Novel Preclinical Model of Retinitis Pigmentosa

Katherine J. Wert, S. Tsang, Chyuan-Sheng Lin, 2013, The Journal of Neuroscience.

Function of the asparagine 74 residue of the inhibitory γ-subunit of retinal rod cGMP-phophodiesterase (PDE) in vivo.

S. Tsang, M. Woodruff, Chyuan-Sheng Lin, 2011, Cellular signalling.

Mouse Models of Achromatopsia in Addressing Temporal “Point of No Return” in Gene-Therapy

S. Tsang, M. Tai, Chyuan-Sheng Lin, 2021, International journal of molecular sciences.

Lentivirus-mediated expression of cDNA and shRNA slows degeneration in retinitis pigmentosa

Jesse D. Sengillo, S. Tsang, Chyuan-Sheng Lin, 2011, Experimental biology and medicine.

Spatiotemporal control of genome engineering in cone photoreceptors

Chyuan-Sheng Lin, J. Sparrow, Chun‐Wei Hsu, 2023, Cell & Bioscience.

Genome Editing in the Retina: A Case Study in CRISPR for a Patient-Specific Autosomal Dominant Retinitis Pigmentosa Model

A. Bassuk, S. Tsang, V. Mahajan, 2016 .

Long-term Safety and Efficacy of Human-Induced Pluripotent Stem Cell (iPS) Grafts in a Preclinical Model of Retinitis Pigmentosa

S. Tsang, D. Egli, Wen-Hsuan Wu, 2012, Molecular Medicine.

Spatiotemporal control of genome engineering in cone photoreceptors

Chyuan-Sheng Lin, J. Sparrow, Chun‐Wei Hsu, 2023, Cell & Bioscience.

F-18 FDG PET/CT in pulmonary alveolar proteinosis.

Chien-Da Huang, Chun‐Wei Hsu, Chih-wei Wang, 2009, Clinical nuclear medicine.

Gene therapy in patient-specific stem cell lines and a preclinical model of retinitis pigmentosa with membrane frizzled-related protein defects.

S. Tsang, L. Yannuzzi, D. Egli, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.